This is a supplement to EyeWorld Magazine.
Issue link: https://supplements.eyeworld.org/i/1490970
44 | 2023 ASCRS ANNUAL MEETING PREVIEW PROGRAM EDUCATION CREDITS • Describe advancements in electronic health records and health information technologies. • Summarize the latest compliance and coding updates. Continuing Education Credit ASOA designates this activity for a maximum of 19.5 credits COE credits and 16.5 CME credits. Attendees should claim only the credit commensurate with the extent of their participation in the activity. ASOA offers various continuing education credits for its 2023 program. Certified Ophthalmic Executive (COE) Attendees: The ASOA Annual Meeting qualifies for COE Category A credits. All attendees seeking COE credits MUST be registered for the ASOA program or the joint ASOA/Technicians & Nurses Program. Speakers: ASOA designates this activity for a maximum of 19.5 COE Category C credits. Attendees registered as exhibitors and guests may not claim education credits for this program. IJCAHPO CREDITS For the Technicians & Nurses Program, evaluations will be distributed at the beginning of each day and collected at the conclusion of each day. International Joint Commission on Allied Health Personnel in Ophthalmology/California Board of Registered Nursing (IJCAHPO/CA BRN) credits will be processed and claimed directly through IJCAHPO. The Technicians & Nurses Program has been approved for credit by IJCAHPO and is CA BRN approved for select courses. A maximum of 16 (IJCAHPO Group A) credits are available for this program. IJCAHPO is an approved provider by the California Board of Registered Nursing, Provider #13516, for Contact Hours. All attendees seeking IJCAHPO/CA BRN credits must be registered for the Technicians & Nurses Program or the joint ASOA/Technicians & Nurses Program. Attendees registered as exhibitors or guests may not claim education credits for this program. Notice About Off-Label Use Presentations The ASCRS ASOA Annual Meeting may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products, or techniques presented.